The Medical Letter on Drugs and Therapeutics
ONLINE
ONLY
ARTICLE
ONLY
ARTICLE
December 9, 2024
Comparison Chart: Antiviral Drugs for Seasonal Influenza for 2024-2025 (online only)
Download PDF: US English
Med Lett Drugs Ther. 2024 Dec 9;66(1717):e1-5 doi:10.58347/tml.2024.1717d
Disclosures
Principal Faculty- Mark Abramowicz, M.D., President has disclosed no relevant financial relationships.
- Jean-Marie Pflomm, Pharm.D., Editor in Chief has disclosed no relevant financial relationships.
Objective(s)
Upon completion of this activity, the participant will be able to:
- Discuss the 2024-2025 recommendations for treatment and chemoprophylaxis of seasonal influenza.
- Compare the antiviral drugs available for treatment of influenza based on their efficacy, dosage and administration, and potential adverse effects.
- Determine the most appropriate regimen for influenza treatment or chemoprophylaxis in a particular patient.
View the Comparison Chart: Antiviral Drugs for Seasonal Influenza for 2024-2025
Download PDF: US English
© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and
complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any
damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
Previous article